Prosomnus Sleep Technologies, Inc. designs, manufactures, and markets sleep apnea therapy devices for dentists to treat patients diagnosed with obstructive sleep apnea. The company was incorporated in 2016 and is based in Pleasanton, California.

ProSomnus, Inc. Common Stock

ProSomnus Sleep Technologies develops therapy solutions for sleep apnea and snoring, offering a device that does not require the use of CPAP machines. Users report a preference for ProSomnus over traditional methods.

ProSomnus Sleep Technologies

ProSomnus® Sleep Technologies | 3,600 followers on LinkedIn. The Leading non-CPAP OSA Therapy™ | ProSomnus (NASDAQ: OSA) is the leading non-CPAP OSA therapy™ for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations.

Len Liptak

Benjamin Roei Gurvitz

Sales and Marketing Executive | Board Advisor | Manufacturing | Med-Tech

Christopher H.

CTO & Co-Founder at ProSomnus® Sleep Technologies

Sung K.

ProSomnus® Sleep Technologies

Did you know? 👉 94% of mild and moderate patients are successfully treated (ODI < 10) with #ProSomnus #precision oral appliances! 👉 Our advanced materials are #healthier , BPA-Free, less porous, #biocompatible and are the highest-Class VI medical grade. 🎉 Our end-of-year cutoff is December 18 🎉 Prescriptions received by this date will be returned to your practice by December 31. Finish the year strong with ProSomnus® Sleep Technologies , the leading non-CPAP OSA therapy. https://prosomnus.com/ #ProSomnus #FinishStrong #OSA #SleepApnea #Provider #Patient

What’s your favorite way to unwind before a good night’s sleep? 😴 I’m a fan of cozy socks and a good book 😊 Dr. Amy Hartsfield and team at TMJ and Sleep Solutions of Homewood, Alabama, stylin’ their new ProSomnus® Sleep Technologies socks. #ProSomnus #SleepTips #Relaxation #OAT #SleepBetter

Providers and patients agree: ProSomnus Sleep solutions are the best option when it comes to comfort, effectiveness, and they're easy to use. Learn more today and take the first step towards better sleep. #ProSomnus #PrecisionOAT #OSA #SleepApnea #DSM

Today, we pause to salute the brave men and women who have served our country with unwavering courage and dedication. Thank you for your service, today and always. We remember and honor you. #VeteransDay #ThankYou #ProSomnus #USA

Left untreated, individuals with obstructive sleep apnea have an elevated risk of Hypertension, Diabetes, Congestive Heart Failure, Depression, and Arythmia. Get sleep tested and take the first step towards better sleep. Visit ProSomnus.com today to get started. #SleepApnea #OSA

🌟 Exciting Weekend for ProSomnus at the 2024 Dental Sleep Medicine Symposium! 🌟 with Nierman Practice Management and Jon Nierman We’re thrilled to be part of the 2024 Dental Sleep Medicine Symposium this weekend in beautiful Ft. Lauderdale, FL! It’s an incredible opportunity to connect, learn, and share the latest innovations in dental sleep medicine. Check out photos of our amazing team members, Gabe Sayer and Lori Barbier , who were on the ground representing ProSomnus® Sleep Technologies . They connected with fellow professionals, exchange insights, and discussed how ProSomnus is revolutionizing sleep solutions for patients everywhere. #DentalSleepMedicine #ProSomnus #SleepApnea #NiermanSymposium2024 #OralApplianceTherapy #BetterSleep

There’s still time to give your patients the gift of better sleep! 💤 ProSomnus® Sleep Technologies is pleased to announce that prescriptions received by December 18 will be returned to your practice by December 31, giving you more time and flexibility to treat your patients effectively during this busy time of year. Finish the year strong with ProSomnus, the leading non-CPAP OSA therapy. #ProSomnus #FinishStrong #OSA #SleepApnea #OAT #TrustedPartner #PatientCare #SleepBetter

Discover better sleep with ProSomnus. Visit ProSomnus.com to explore modern sleep apnea solutions. #ProSomnus #OSA #SleepApnea #DentalSleepMedicine #PrecisionOAT

Obstructive Sleep Apnea (OSA) doesn't just disrupt your sleep, it can impact your overall well-being and your health. Affecting millions around the globe, this condition requires effective solutions. ProSomnus Sleep devices are FDA-cleared and backed by clinical evidence to help you breathe easier and sleep soundly. Discover a healthier, more restful night with ProSomnus. #BetterSleep #SleepApnea #SleepDentist #ProSomnus

🚨 Register now for the Tufts University School of Medicine “First Global TMD & Sleep Symposium – Medical & Dental Sleep Apnea Management, New Diagnostic & Therapeutic Paradigms”, March 14-15, 2025 in Athens, Greece! This hybrid (In-person and live-streamed) Symposium is hosted by the Tufts University School of Medicine and the Hellenic Society of Odontostomatological Research (HSOR) with key Directors: John E. Remmers, MD; Noshir R. Mehta, BDS, DMD, MDS, MS; Jonathan Parker, DDS; and Prof. Marc Braem, DDS, PhD. 🗓️: March 14-15, 2025 📍: Athens, Greece 🔗: https://loom.ly/VQQYQ3U #Tufts #ProSomnus #OSA #DSM #SleepEducation #Sleep #Symposium #Greece

	Dec '20	Dec '21	Dec '22	Dec '23
revenue	8.29M -	14.07M 69.86%	19.39M 37.79%	27.65M 42.59%
cost of revenue	4.17M -	6.76M 62.38%	9.13M 34.93%	13.64M 49.45%
gross profit	4.12M -	7.31M 77.42%	10.27M 40.43%	14.01M 36.48%
selling and marketing expenses	3.52M -	5.78M 64.28%	8.87M 53.48%	13.09M 47.60%
general and administrative expenses	3.29M -	4.46M 35.49%	9.89M 121.86%	15.23M 53.92%
selling general and administrative expenses	6.81M -	10.24M 50.36%	18.76M 83.28%	28.32M 50.93%
research and development expenses	1.47M -	1.89M 28.45%	2.98M 57.81%	4.80M 61.07%
other expenses	10K -
cost and expenses	12.44M -	18.89M 51.80%	30.87M 63.42%	46.76M 51.47%
operating expenses	8.28M -	12.13M 46.47%	21.74M 79.31%	33.12M 52.32%
interest expense	2.01M -	3.25M 61.67%	6.12M 88.58%	-5.38M 187.94%
ebitda	-3.57M -	-3.99M 11.54%	-11.48M 187.80%	-19.11M 66.49%
operating income	-4.15M -	-4.81M 16.08%	-1.03M 78.70%	-19.11M 1,763.07%
depreciation and amortization	573.27K -	827.57K 44.36%	-10.45M 1,362.73%
total other income expenses net	-2.01M -	-1.15M 42.47%	-6.12M 429.91%
income before tax	-6.16M -	-5.97M 3.02%	-7.15M 19.69%
income tax expense	17.66K -	7.65K 56.68%	-10.45M 136,665.33%
net income	-6.17M -	-5.98M 3.17%	3.30M 155.29%
weighted average shs out	16.05M -	16.05M 0%	16.04M 0.04%	16.18M 0.84%
weighted average shs out dil	16.05M -	16.05M 0%	16.04M 0.04%	16.18M 0.84%
eps	-0.38 -	-0.37 2.63%	0.21 156.76%	0 100%
epsdiluted	-0.38 -	-0.37 2.63%	0.21 156.76%	0 100%

COM:PROSOMNUS

ProSomnus Sleep Technologies

Last Close

0.47

16/01 21:00

Market Cap

8.18M

Beta: -

Volume Today

58.85K

Avg: -

Preview